What are the causes of hematuria in children, and what investigations and drug treatments are recommended for management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hematuria in Children: Causes, Investigations, and Management

For isolated microscopic hematuria without proteinuria or dysmorphic red blood cells in children, no imaging is indicated and clinical observation is appropriate, as these patients are unlikely to have clinically significant renal disease 1.

Causes of Hematuria in Children

The differential diagnosis varies by clinical presentation:

Glomerular Causes

  • Postinfectious glomerulonephritis (most common glomerulonephritis in children) 2
  • IgA nephropathy (Berger disease) - requires renal biopsy for diagnosis 1
  • Alport syndrome - suspect with family history of hearing loss or renal disease 1
  • Thin basement membrane nephropathy - most common cause of persistent microscopic hematuria, usually benign 1, 2
  • Henoch-Schönlein purpura
  • Systemic lupus erythematosus

Non-Glomerular Causes

  • Urinary tract infection - most common overall cause 2, 3
  • Hypercalciuria - found in 33.7% of children with idiopathic hematuria 4
  • Hyperuricosuria - present in 35.8% of cases 4
  • Urolithiasis
  • Trauma (blunt or penetrating)
  • Sickle cell disease
  • Coagulopathy

Metabolic Abnormalities

94% of children with idiopathic hematuria have urinary metabolic abnormalities, most commonly hypocitraturia (60.7%) and hypomagnesuria (58.2%) 4.

Algorithmic Approach to Investigation

Step 1: Clinical History - Key Red Flags

Look specifically for:

  • Tea-colored urine (suggests glomerular source) 1
  • Recent streptococcal infection
  • Hearing loss or family history of renal disease (Alport syndrome)
  • Rash, arthritis, bloody diarrhea (systemic disease)
  • Trauma history
  • Strenuous exercise
  • Menstruation in adolescent females
  • Family history of sickle cell disease, hemophilia, or nephrolithiasis 1

Step 2: Urinalysis with Microscopy

Critical findings that determine next steps:

  • Proteinuria >2+ by dipstick + dysmorphic RBCs + RBC casts = glomerular disease requiring nephrology referral 1
  • White cells + organisms = UTI, treat accordingly
  • Isolated microscopic hematuria (≥5 RBCs/HPF in 2-3 consecutive specimens) without proteinuria = low risk 1

Step 3: Initial Laboratory Testing

For all patients with persistent hematuria:

  • Spot urine calcium-to-creatinine ratio (evaluate hypercalciuria) 1
  • Urine culture 1

When chronic kidney disease suspected:

  • Blood urea nitrogen
  • Serum creatinine
  • Complete blood count with platelets 1

For glomerular disease suspected:

  • Complement levels (C3, C4)
  • Antistreptolysin O titer
  • Anti-DNase B
  • ANA, anti-dsDNA (if lupus suspected)
  • Audiogram and slit lamp examination if Alport syndrome suspected 1

Step 4: 24-Hour Urine Collection for Metabolic Evaluation

Strongly recommended for isolated idiopathic hematuria 4:

  • Calcium, citrate, oxalate, phosphate
  • Uric acid, cystine, magnesium
  • This identifies treatable metabolic causes in 94% of cases

Step 5: Imaging - Clinical Scenario-Based

Isolated microscopic hematuria WITHOUT proteinuria:

  • No imaging indicated 1
  • Exception: Consider renal ultrasound if hypercalciuria or hyperuricosuria documented to evaluate for stones 1

Hematuria WITH proteinuria or dysmorphic RBCs:

  • Renal ultrasound to assess kidney size, position, and structural abnormalities before potential biopsy 1

Painful hematuria:

  • Renal ultrasound first-line to evaluate for stones, obstruction

Post-traumatic macroscopic hematuria:

  • CT urography to identify extent of renal/urinary tract injury 1

Post-traumatic microscopic hematuria:

  • Clinical observation typically sufficient

Important caveat: CT is NOT appropriate for isolated nonpainful, nontraumatic hematuria 1

Drug Treatment Recommendations

For Hypercalciuria-Associated Hematuria

Potassium citrate supplementation is highly recommended to prevent future stone formation and treat hematuria 4. This addresses the most common metabolic abnormality (hypocitraturia in 60.7% of cases).

For Urinary Tract Infection

Appropriate antibiotics based on culture and sensitivity

For Glomerulonephritis

Treatment depends on specific diagnosis:

  • Postinfectious glomerulonephritis: supportive care, manage hypertension and edema
  • IgA nephropathy: ACE inhibitors/ARBs if proteinuria present
  • Lupus nephritis: immunosuppression per nephrology
  • Alport syndrome: ACE inhibitors/ARBs to slow progression

For Idiopathic Hematuria with Metabolic Abnormalities

Potassium citrate for hypocitraturia and hypercalciuria 4

Critical Clinical Pitfalls

  1. Do not over-image isolated microscopic hematuria - 87% of children in one study had renal ultrasound with no clinically significant findings 1

  2. Screen family members' urine for persistent unexplained microhematuria to identify benign familial hematuria 1

  3. Proteinuria changes everything - presence of proteinuria with hematuria mandates nephrology evaluation for glomerular disease 1, 5

  4. Most isolated microscopic hematuria is benign - 88.5% have microscopic hematuria with benign course, requiring only clinical observation 4, 2

  5. Measure urinary biochemistry in all children with isolated hematuria, as 94% have treatable metabolic abnormalities 4

  6. Refer to pediatric nephrology when:

    • Hematuria persists >2 weeks after glomerulonephritis onset
    • Renal biopsy needed
    • Persistent microscopic hematuria with unclear etiology 5

References

Guideline

acr appropriateness criteria<sup>®</sup> hematuria-child.

Journal of the American College of Radiology, 2018

Research

Approach to the Child with Hematuria.

Pediatric clinics of North America, 2019

Research

Haematuria in children.

British journal of hospital medicine (London, England : 2005), 2021

Research

Approach to Diagnosis and Management of Hematuria.

Indian journal of pediatrics, 2020

Related Questions

What investigations should be performed for hematuria?
What are the possible causes of hematuria in a 13-year-old boy?
How should a single episode of hematuria be evaluated and managed in an incontinent elderly patient?
What is the imaging study of choice for evaluating gross hematuria in an adult patient?
What is the recommended approach to evaluate and manage microscopic hematuria?
What is the recommended rifaximin dosage for a 13-year-old child?
How should diabetic nephropathy be treated, including antihypertensive therapy (ACE inhibitor or ARB), SGLT2 inhibitor use, glycemic control, dietary sodium and protein restriction, lipid management, and additional agents for persistent albuminuria?
How can I create a one‑hour PowerPoint presentation for DNB instructors on the management of respiratory tract infections, emphasizing antibiotic selection, treatment duration, de‑escalation, resistance patterns, and incorporating difficult multiple‑choice questions with a concise take‑home message?
What anticoagulation should be initiated for a patient who has been off their home apixaban (Eliquis) for several days after a recent pacemaker implantation?
What is the most likely diagnosis and recommended next diagnostic and therapeutic steps for a patient with markedly elevated fecal calprotectin (~1589 µg/g), presence of fecal leukocytes, and a negative infectious stool workup (negative Clostridioides difficile PCR, negative bacterial culture, and no ova/parasites)?
What is the appropriate management for a hyperglycemic patient with elevated blood urea nitrogen (108 mg/dL), creatinine 2.67 mg/dL, urine output 900 mL, and hypernatremia (serum sodium 154 mEq/L)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.